Détail du congrès:
Congrès: Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) (9-13 mai 2005)
Commentaire :
AFM
Auteur(s) ayant un renvoi vers celui-ci :
|
Documents disponibles provenant de ce congrès (411)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Esquivel-Solís H ; Perez-Carreon JI ; Fattel-Fazenda S ; Martinez-Perez F ; Villa-Trevino S ; Martinez-Rojas D | 2005Communication n° 163 The Dp71 associated protein complex (Dp71~DAPC) has been implicated in cell adhesion, differentiation and embryonic development. Moreover, the DAPC members, who connect the extracellular matrix to the cytoskeleton, a- and b-[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Garces A ; Ohayon D ; Mechaly I ; Valmier J ; Carroll P | 2005Communication n° 721. We still have a rather primitive understanding of the molecular mechanisms that underlie vertebrate sensory-motor system establishment, physiology and physiopathology. Although a series of novel techniques have been develop[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Chartier A ; Simonelig M | 2005Communication n° 637. Oculopharyngeal muscular dystrophy (OPMD) is a late onset disease characterized by eyelid drooping, swallowing difficulties and limb weakness. OPMD results from dominant mutation (GCG triplet expansions) in the poly(A) bind[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Marti I ; Demeer B ; Angeard N ; Ben Yaou R ; Daoud F ; Saillour Y ; Récan D ; Heron D ; Rivier F ; Desguerre I ; Tuffery S ; Cossee M ; Leturcq F ; Cuisset JM ; Kaplan JC ; Chelly J | 2005Communication n° 527 Duchenne and Becker muscular dystrophinopathies (DMD and BMD) are allelic X-linked diseases characterized by progressive muscular degeneration, responsible for muscle weakness, and associated with cognitive impairment in app[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Freixas A ; Gallardo E ; de Luna N ; Bautista J ; Marquez C ; Pardo J ; Pou A ; Vilchez J ; Rodriguez MJ ; Baiget M ; Illa I ; Gallano P | 2005Communication n° 394 Mutations in dysferlin gene (DYSF) cause different muscular dystrophy phenotypes including Limb Girdle Muscular Dystrophy 2B (LGMD2B), Miyoshi Myopathy (MM) and Distal Anterior Compartment myopathy (DAT). These disorders are[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Petrucci TC ; Ceccarini M ; Torreri P ; Bernassola M ; Macchia G ; Macioce P | 2005Communication n° 348. b-Dystrobrevin is a member of the dystrophin-related and -associated protein family, highly expressed in brain, lung and kidney. In brain b-dystrobrevin is highly enriched at the postsynaptic membrane in hippocampal and Pur[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Bogdanik L ; Mornet D ; Bockaert J ; Parmentier Ml ; Grau Y | 2005Communication n° 651 Many muscular dystrophies result from a weak muscle membrane linkage mediated through dystrophin associations with transmembrane proteins such as dystroglycan (DG). Then this dystrophin-dystroglycan complex is essential for [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Le Rumeur E ; Pottier S ; Gaboriau F ; Hardy S | 2005Communication n° 87. Dystrophin is the protein genetically deficient in Duchenne Muscular Dystrophy (DMD). Its C-and N-terminal ends interact with several cytoskeletal and membrane proteins, thus establishing a link between the cytoskeleton and [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Keyhani E ; Kahrizi K ; Shafeghati Y ; Azimi P ; Darabi E ; Najmabadi H | 2005Communication n° 434 Introduction : Duchenne Muscular Dystrophy (DMD)is one of the most lethal forms of muscular dystrophies. In Iran, despite the high frequency of the disease, there was no laboratory facilities to detect the disease till thirt[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Mongue-Din H ; Salmon A ; Fiszman M ; Fromes Y | 2005Communication n° 201 Familial myopathies are due to primary molecular alterations of striated skeletal and cardiac cells. During cardiomyopathies evolution, patients develop secondary alterations characterized by an abnormal cardiac electric act[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Carmignac V ; Quijano Roy S ; Urtizberea JA ; Eymard B ; Romero NB ; Campbell K ; Morandi L ; Bertini E ; Salih M ; Guicheney P ; Estournet Mathiaud B ; Ferreiro A | 2005Communication n° 520 Salih Congenital Muscular Dystrophy (Salih CMD) was described in 1998 in two brothers presenting with neonatal hypotonia, axial and proximal weakness and severe dilated cardiomyopathy leading to death in adolescence. The gen[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Vandebrouck C ; Basset O ; Ducret T ; Sebille S ; Raymond G ; Gailly P ; Cognard C ; Constantin B | 2005Communiation n° 215 Duchenne Muscular Dystrophy results from the lack of dystrophin, a cytoskeletal protein associated with the inner surface membrane, in skeletal muscle. The absence of dystrophin induces an abnormal increase of sarcolemmal cal[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Treves S ; Ducreux S ; Muller C ; Muntoni F ; Sewry C ; Quinlivan R ; Girard T ; Zorzato F | 2005Communication n° 12. Introduction and objectives : More than 60 mutations in the skeletal muscle RYR1 gene have been identified and associated with Malignant Hyperthermia (MH) and Central Core Disease (CCD). Most MH-linked mutations are localise[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Ollivier K ; Hogrel JY ; Gomez-Merino D ; Leroy-Willig A ; Ait Ahmed M ; Berkani M ; Doppler V ; Chevrot M ; Laforet P ; Eymard B ; Portero P | 2005Communication n° 281. Introduction : McArdle's disease is a metabolic myopathy of genetic origin. It is characterised by a severe effort intolerance due to myophosphorylase deficiency. Patients present, often from childhood, an excessive fatigue[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Berrih-Aknin S ; Poëa-Guyon S ; Christadoss P ; Le Panse R ; Guyon T ; Bidault J ; Tzartos SJ | 2005Communication n° 590 Myasthenia gravis (MG) is an autoimmune disease associated with thymic pathologies, including hyperplasia. In this study we investigated the processes that may lead to thymic overexpression of the triggering antigen, the ace[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Cazorla O ; Szilagyi S ; Vignier N ; Kulikovskaya ; Winegrad S ; Vassort G ; Carrier L ; Lacampagne A | 2005Communication n° 551. b-adrenergic stimulation modulates cardiac contractility through protein kinase A (PKA), which phosphorylates cellular proteins, such as cardiac troponin I (cTnI) and cardiac C-protein (cMyBP-C). The relative contributions [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Vignaud A ; Caruelle JP ; Martelly I ; Ferry A | 2005Communication n° 376. Introduction : Concerning skeletal muscle regeneration, little information exists on differences between animal strains, long-term recovery, or differences between rapidly growing and adult animals. Such data should provide[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Laforet P ; Hammouda EH ; Hogrel JY ; Attarian S ; Ollivier G ; Doppler V ; Pouget J ; Desnuelle C ; Payan C | 2005Communication n° 754 Introduction: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most frequent inherited neuromuscular disorder, with autosomal dominant transmission. This disorder is slowly progressive, involving preferentially th[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Goncalves M ; Holkers M ; Cudre-Mauroux C ; van Nierop GP ; Knaan-Shanzer S ; Valerio D ; de Vries A | 2005Communication n° 293 Introduction : Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene, making it amenable to gene- or cell-based therapies. Another possible treatment entails the combination of both principles by tr[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Arvieux CC ; Pennec JP ; Guéret G ; Metges MA ; Rossignol B ; Dorange G ; Gioux M | 2005Communication n° 458 Introduction : Critical illness polyneuropathy (CIP) remains to be delineated since it includes several nervous and muscular entities occurring after a sepsis in critically ill patients. Few data are available on the cellula[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Auda-Boucher G ; Rouaud T ; Lafoux A ; Huchet-Cadiou C ; Fontaine-Perus J ; Gardahaut M | 2005Communication n° 249. We previously demonstrated that CD34+/Flk1+ vascular endothelial cells from the mouse embryonic muscles (17d.p.c.) have the ability to predominantly differentiate in vitro into skeletal muscle lineage and to restore dystrop[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; McVie-Wylie AJ ; Rogers C ; Thurberg BL ; Zhang M ; Madden S ; Klinger K ; O'Callaghan M ; Andrews L ; Mattaliano R | 2005Communication n° 579 Pompe disease is an autosomal recessive neuromuscular disorder of lysosomal glycogen metabolism resulting from deficiency of the enzyme acid alpha-glycosidase (GAA). A GAA knockout mouse model has been generated in which the[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Martinez Perea de Posadas M ; Multicenter Study S ; Many Hospital,Multicenter S | 2005Communication n° 90 INTRODUCTION : About 0.2 % of the disabled population suffer from an inherited Neuromsucular Disorders (NMD). There are no current data about Neuromuscular Diseases Incidence in our country.Each entity presents relative frequ[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Jory A ; Tajbakhsh S | 2005Communication n° 484. Muscle Progenitor Cells (MPCs; Myf5+) and their ancestors in mice are born in the dorsal (epaxial) and ventral (hypaxial) lips of the somite dermomyotome (DM) epithelium. Pax3 and Pax7 mark essentially all cells in the DM. [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Davoust J ; Ginhoux F ; Turbant S ; LeBoeuf MB ; Gross D ; Lemonnier F ; Goyenvalle A ; Garcia L ; Danos O | 2005Communication n° 668 Cellular immune responses may compromise long-term expression in Dystrophin-based gene therapy treatments. To predict cytotoxic T-cell responses mediated by dystrophin (DYST), we designed a new H-2-negative HLA-A*0201 transg[...]